Skip to main content
Clinical Trials/IRCT2016102323235N5
IRCT2016102323235N5
Completed
Phase 3

A clinical trial to evaluate the effect of topical liposomal formulation of Althaea officinalis and compare it with topical hydrocortisone acetate (1%) ointment in improving and control symptom in patients with atopic eczema

Vice chancellor for research, Mashhad University of Medical Sciences0 sites40 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Atopic Eczema.
Sponsor
Vice chancellor for research, Mashhad University of Medical Sciences
Enrollment
40
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice chancellor for research, Mashhad University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Confirm eczema atopic dermatitis by an allergist according to plan; family history of atopy; positive allergy tests (skin prick test) ; Complete the consent form
  • Exclusion criteria
  • Local sensitivity to new formulations; Patients with diseases of the skin; Systemic immunosuppressive drugs; Lack of cooperation during treatment; waste infections that require antibiotics or drug penetration increase; patients with atopic eczema lesions with high emissions (over 50%) of body surface

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials